Coexisting hyperparathyroidism and oncogenic osteomalacia: Sestamibi and somatostatin receptor scintigraphy.
Nguyen
Ba D
BD
Department of Radiology, Mayo Clinic, Scottsdale, Arizona 85259, USA. nguyyen.ba@mayo.edu
D006801:Humans; D006961:Hyperparathyroidism / Q000150:complications* / Q000000981:diagnostic imaging*; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000031:analogs & derivatives*; D010018:Osteomalacia / Q000150:complications* / Q000000981:diagnostic imaging*; D010257:Paraneoplastic Syndromes / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi
D019275:Radiopharmaceuticals; C094279:indium-111-octreotide; D017256:Technetium Tc 99m Sestamibi; D015282:Octreotide